毛杭子梢中黄酮类成分的分离鉴定及活性测定Flavonoids from Campylotropis hirtella(Franch.) Schindl. and their bioactivities
文屏,韩慧英,王乃利,姚新生
WEN Ping1,HAN Hui-ying1,WANG Nai-li2,YAO Xin-sheng1 (1.School of Traditional Chinese Materia Medica
摘要(Abstract):
目的研究毛杭子梢体积分数为60%的乙醇提取物的化学成分,寻找新的抗前列腺增生的活性化合物。方法运用D101大孔树脂、硅胶柱色谱、LH-20葡聚糖凝胶柱色谱、ODS反相柱、制备液相等分离手段对毛杭子梢体积分数为60%的乙醇提取物进行分离,并根据光谱数据鉴定化合物的结构;采用酶联免疫法(ELISA)评价单体化合物抑制前列腺癌细胞(LNCaP细胞)分泌前列腺特异性抗原的作用。结果从该植物中分得1个新的黄酮类化合物和6个已知的黄酮类化合物,结构分别被鉴定为2,7,4′-三羟基二氢黄酮-5-O-β-D-葡萄糖苷(2,7,4-′trihydroxyflavanone-5-O--βD-glucopyranoside,1)、7,2′-二甲氧基-5,4′-二羟基二氢异黄酮(cajanol,2)、染料木素(genistein,3)、柚皮素(naringenin,4)、二氢山柰酚(dihydrokaempferol,5)、槲皮素(quercetin,6)、山柰酚(kaempferol,7)。黄酮苷元类化合物2~7显示了不同强度的抑制前列腺癌细胞(LNCaP细胞)分泌前列腺特异性抗原活性,其半数抑制率(IC50)分别为194.6、94.4、17.2、113.5、25.8、7.2μmol.L-1,黄酮苷类化合物1则不具有活性。结论化合物1为新化合物,化合物2~7均为首次从该属中分离得到;活性测试结果表明,黄酮苷元可能为毛杭子梢中抗前列腺增生的主要活性成分。
Objective To study the chemical constituents from the 60% ethanol extract of the roots of Campylotropis hirtella(Franch.) Schindl.and search for new active compounds for the treatment of prostate benign hyperplasia.Methods Compounds were isolated through various chromatographic methods and identified by spectroscopic data;their inhibitory effect were tested on prostate specific antigen secretion in LNCaP cells by enzyme-linked immumosorbent assay(ELISA) method.Results One new compound and six known compounds were obtained.Their structures were confirmed as 2,7,4′-trihydroxyflavanone-5-O-β-D-glucopyranoside (1),isoferreirin (2),genistein (3),naringenin (4),dihydrokaempferol (5),quercetin (6) and kaempferol (7).The inhibitory activities of these compounds were examined on prostate specific antigen secretion in LNCaP cells by ELISA method,and IC50 of the compounds 2-7 were 194.6,94.4,17.2,113.5,25.8 and 7.2 μmol·L-1,respectively.Compound 1 had no obvious effect.Conclusions Compound 1 is a new compound and the other six compounds are isolated from the genus Campylotropis for the first time.Flavonoids show obvious inhibitory effect on prostate specific antigen secretion in LNCaP cells.
关键词(KeyWords):
毛杭子梢;黄酮;前列腺增生
Campylotropis hirtella;flavonoid;prostate hyperplasia
基金项目(Foundation):
作者(Author):
文屏,韩慧英,王乃利,姚新生
WEN Ping1,HAN Hui-ying1,WANG Nai-li2,YAO Xin-sheng1 (1.School of Traditional Chinese Materia Medica
参考文献(References):
- [1]江苏新医学院.中药大辞典[M].上海:上海人民出版社,2001:2396.
- [2]HAN Hui-ying,LIU Hong-wei,YAO Xin-sheng,et al.Sesquilignans and dilignans fromCampylotropishirtella(Franch.)Schindl[J].Nature Product Re-search(in press).
- [3]JAGROOP S D,RIHARD N S,KENVIN G B,et al.Two isoprenylated isoflavone phytolexins fromCajanusCajan[J].Phytochemistry,1984,23(4):871-873.
- [4]徐德平,江汉湖,庞自洁.丹贝异黄酮的提取分离与结构鉴定[J].食品与发酵工业,2001,27(3):1-4.
- [5]任冬梅,娄红祥,季梅.岩青兰化学成分的研究[J].中国药学杂志,2005,40(22):1695-1696.
- [6]BEATE B,PETER W.Isolation and characterizationof novel benzoates,cinnamates,flavonoids,and lignansfrom riesling wine and screening for antioxidantactivity[J].J Agric Food Chem,2001,49(6),2788-2798.
- [7]李霄,石任兵,刘斌,等.清脑宣窍方有效部位的化学成分研究(Ⅱ)[J].北京中医药大学学报,2006,29(8):545-550.
- [8]魏玉辉,武新安,张承忠,等.光茎大黄化学成分研究(Ⅱ)[J].中国药学杂志,2006,41(4):253-254.
- [9]HAN Hui-ying,SHAN Song,ZHANG Xue,et al.Down-regulation of prostate specific antigen in LNCaPcell by flavonoids from the pollen ofBrassica napusL[J].Phytomedicine,2007,14:338-343.
- [10]DENISA M S,MORTONB K G.Diet and its preven-tive role in prostatic disease[J].Eur Urol,1999,35:377-387.
- [11]COLM M,WILLIAM G W.Phytoestrogens andprostate cancer[J].Current Drug Targets,2003(4):231-241.
- [12]PEMELA J M,IAN R R.Phyto-oestrogens,theirmechanism of action:Current evidence for a role inbreast and prostate cancer[J].British Journal of Nu-trition,2004,91:513-531.
- [13]BANDANA C.The role of the androgen receptor inthe development of prostatic hyperplasia and prostatecancer[J].Molecular and Cellular Biochemistry,2003,253:89-101.
- [14]XING Nian-zeng,CHEN Yi,MITCHELL S H.Quercetin inhibits the expression and function of theandrogen receptor in LNCaP prostate cancer cells[J].Carcinogenesis,2001,22(3):409-414.
- [15]THELEN P,SESEKE F,RINGERT R H,et al.Phar-macological potential of phytoestrogens in the treat-ment of prostate cancer[J].Urologe A,2006,45(2):195-201.
- [16]JOANNE N D,OMER K,FAZLUL H S.Expressionof prostate-specific antigen is transcriptionally regulat-ed by genistein in prostate cancer cells[J].MolecularCarcinogenesis,2002,34:91-101.